Business Context and Reporting Period
Company: Xtant Medical Holdings, Inc. (XTNT)
Filing Type: Form 8-K (Current Report)
Report Date: March 31, 2026
Period Covered: The filing announces financial results for the three months and full year ended December 31, 2025.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed figures. Consequently, specific numerical values for the following metrics are not present in this document:
- Revenue: Not provided in text.
- Profit/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Non-GAAP Measures: The Company utilizes "Non-GAAP Adjusted EBITDA" to assess core operational performance. This metric adjusts net income by excluding depreciation, amortization, interest, taxes, non-cash compensation, divestiture/acquisition-related expenses, gains on divestiture, fair value adjustments, unrealized foreign currency translation gains/losses, and separation-related expenses.
Material Changes and Comparisons
The filing text does not contain specific comparative data or material changes versus prior periods. It states that the Company excludes certain items from Non-GAAP Adjusted EBITDA to facilitate period-over-period comparability, but the actual results of these comparisons are located in the referenced press release.
Guidance, Outlook, and Risks
Management Commentary: Management uses Non-GAAP Adjusted EBITDA to guide budgeting, spending decisions (specifically in sales, marketing, and R&D), and resource allocation. They believe this measure removes the impact of unpredictable charges and non-cash items to better reflect ongoing business operations.
Risks and Contingencies: The filing includes standard disclaimers that Non-GAAP measures are not in accordance with GAAP, may differ from measures used by other companies, and should not be viewed as an alternative to GAAP measures. The text notes that Non-GAAP measures have limitations as they do not reflect all amounts associated with financial results.
Unusual Items: The Company identifies the following as items excluded from core profitability analysis: non-cash compensation, divestiture/acquisition expenses, gains on divestiture, acquisition-related fair value adjustments, unrealized foreign currency translation, and separation-related expenses.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and Full Year 2025.
- Verify the reconciliation table between GAAP Net Income and Non-GAAP Adjusted EBITDA to understand the magnitude of excluded items.
- Confirm the specific impact of the divestiture of non-core Coflex/CoFix assets and the international hardware business on current operations.
- Check for any updated forward-looking guidance or outlook statements in the full press release, as none are included in this 8-K summary.